Ekblom Anders bought MREO
February 8, 2024 · Form 4 insider transaction
Ekblom Anders bought 45,000 shares of Mereo BioPharma Group plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
45,000
Price
$0.00
Total value
N/A
InsiderEkblom Anders
RoleDirector
SecurityShare Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 8, 2024
Filing dateFebruary 9, 2024
Shares owned after45,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Vests in substantially equal monthly installments over a one year period from the February 8, 2024 grant date.; Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.